Anastomosis, Surgical
0
Pipeline Programs
3
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
GT Metabolic SolutionsMN - St. Michael
1 programSide-to-side duodenal-ileal anastomosisN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2025
2026
2027
MicrosureRobot-assisted microsurgical anastomoses
GT Metabolic SolutionsSide-to-side duodenal-ileal anastomosis
Clinical Trials (2)
Total enrollment: 136 patients across 2 trials
Evaluation of MUSA-3 in Microsurgical Anastomoses
Start: Apr 2026Est. completion: Sep 202630 patients
N/ANot Yet Recruiting
MagDI U.S. Registry
Start: Mar 2025Est. completion: Apr 2027106 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 136 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.